2023-07-19T00:51:08Z
ENA-FIRST-PUBLIC
2023-07-19T00:51:08Z
ENA-LAST-UPDATE
SAMN31739604
External Id
GSM6732499
External Id
2023-07-19T00:51:08Z
INSDC first public
2023-07-19T00:51:08Z
INSDC last update
public
INSDC status
SRS15765459
SRA accession
GSM6732499
Submitter Id
NCBI
broker name
Expanded TIL
cell line
CD8+
cell type
H3 pan-acetyl
chip antibody
missing
collection_date
human
common name
1
dataset
female
gender
missing
geo_loc_name
65.50%
infusion percent_cd4
23.40%
infusion percent_cd8
3.26E+10
number til_infused
Homo sapiens
organism
22
overall survival_months
1
pfs censor_at_12_months
2
pfs months
PD
response
Homo sapiens
scientific_name
TIL ACT Product
source_name
1
survival censor
TIL ACT Product
tissue
Patient 10 CD8+ [Pt10_CD8]
title
TIL ACT
treatment
15781
trial